VG Life Sciences Inc.
Get $10 bonus on your first $100 deposit for VGLS
Get $10 bonus on your first $100 deposit for VGLS
VG Life Sciences Inc. (VGLS) Stock Competitors & Peer Comparison
See (VGLS) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VGLS | $0.13 | +124900.00% | 2.6B | N/A | N/A | N/A |
| NONOF | $38.42 | -5.33% | 176.5B | 11.07 | $3.59 | +4.63% |
| CSLLY | $24.79 | +0.49% | 96B | 16.10 | $1.54 | +2.95% |
| UCBJF | $305.59 | +1.32% | 61.4B | 34.29 | $9.41 | +0.49% |
| UCBJY | $154.93 | +1.89% | 58.6B | 32.76 | $4.70 | +0.51% |
| ARGNF | $894.76 | +25.66% | 55.4B | 45.70 | $19.58 | N/A |
| CMXHF | $97.43 | -2.88% | 47.3B | 15.79 | $6.17 | +3.00% |
| WXXWY | $9.39 | -1.16% | 19.3B | 27.42 | $0.34 | N/A |
| IVBXF | $11.11 | -0.77% | 19.1B | 158.73 | $0.07 | N/A |
| WXIBF | $4.60 | +0.00% | 19B | 27.06 | $0.17 | N/A |
Stock Comparison
VGLS vs NONOF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, NONOF has a market cap of 176.5B. Regarding current trading prices, VGLS is priced at $0.13, while NONOF trades at $38.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 11.07. In terms of profitability, VGLS's ROE is +0.00%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, VGLS is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check NONOF's competition here
VGLS vs CSLLY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CSLLY has a market cap of 96B. Regarding current trading prices, VGLS is priced at $0.13, while CSLLY trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 16.10. In terms of profitability, VGLS's ROE is +0.00%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, VGLS is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CSLLY's competition here
VGLS vs UCBJF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, UCBJF has a market cap of 61.4B. Regarding current trading prices, VGLS is priced at $0.13, while UCBJF trades at $305.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 34.29. In terms of profitability, VGLS's ROE is +0.00%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, VGLS is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check UCBJF's competition here
VGLS vs UCBJY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, UCBJY has a market cap of 58.6B. Regarding current trading prices, VGLS is priced at $0.13, while UCBJY trades at $154.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 32.76. In terms of profitability, VGLS's ROE is +0.00%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, VGLS is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check UCBJY's competition here
VGLS vs ARGNF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ARGNF has a market cap of 55.4B. Regarding current trading prices, VGLS is priced at $0.13, while ARGNF trades at $894.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 45.70. In terms of profitability, VGLS's ROE is +0.00%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, VGLS is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ARGNF's competition here
VGLS vs CMXHF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CMXHF has a market cap of 47.3B. Regarding current trading prices, VGLS is priced at $0.13, while CMXHF trades at $97.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 15.79. In terms of profitability, VGLS's ROE is +0.00%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, VGLS is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CMXHF's competition here
VGLS vs WXXWY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, WXXWY has a market cap of 19.3B. Regarding current trading prices, VGLS is priced at $0.13, while WXXWY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 27.42. In terms of profitability, VGLS's ROE is +0.00%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, VGLS is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check WXXWY's competition here
VGLS vs IVBXF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, IVBXF has a market cap of 19.1B. Regarding current trading prices, VGLS is priced at $0.13, while IVBXF trades at $11.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is 158.73. In terms of profitability, VGLS's ROE is +0.00%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, VGLS is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check IVBXF's competition here
VGLS vs WXIBF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, WXIBF has a market cap of 19B. Regarding current trading prices, VGLS is priced at $0.13, while WXIBF trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 27.06. In terms of profitability, VGLS's ROE is +0.00%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, VGLS is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check WXIBF's competition here
VGLS vs GNMSF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, GNMSF has a market cap of 17.4B. Regarding current trading prices, VGLS is priced at $0.13, while GNMSF trades at $281.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 18.34. In terms of profitability, VGLS's ROE is +0.00%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, VGLS is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check GNMSF's competition here
VGLS vs SBHMY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, VGLS is priced at $0.13, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 41.82. In terms of profitability, VGLS's ROE is +0.00%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, VGLS is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SBHMY's competition here
VGLS vs SBMFF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, VGLS is priced at $0.13, while SBMFF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 25.33. In terms of profitability, VGLS's ROE is +0.00%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, VGLS is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SBMFF's competition here
VGLS vs BRRGF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, VGLS is priced at $0.13, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, VGLS's ROE is +0.00%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, VGLS is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for VGLS.Check BRRGF's competition here
VGLS vs AAVXF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, VGLS is priced at $0.13, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, VGLS's ROE is +0.00%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, VGLS is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check AAVXF's competition here
VGLS vs ODTC Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, VGLS is priced at $0.13, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is 1.07. In terms of profitability, VGLS's ROE is +0.00%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, VGLS is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ODTC's competition here
VGLS vs TRSBF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, TRSBF has a market cap of 7.1B. Regarding current trading prices, VGLS is priced at $0.13, while TRSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 21.43. In terms of profitability, VGLS's ROE is +0.00%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, VGLS is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check TRSBF's competition here
VGLS vs AKBLF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, VGLS is priced at $0.13, while AKBLF trades at $31.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 37.32. In terms of profitability, VGLS's ROE is +0.00%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, VGLS is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check AKBLF's competition here
VGLS vs REGMF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, VGLS is priced at $0.13, while REGMF trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is 57.63. In terms of profitability, VGLS's ROE is +0.00%, compared to REGMF's ROE of +0.27%. Regarding short-term risk, VGLS is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check REGMF's competition here
VGLS vs ABCZF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, VGLS is priced at $0.13, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, VGLS's ROE is +0.00%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, VGLS is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ABCZF's competition here
VGLS vs LABFF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, VGLS is priced at $0.13, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, VGLS's ROE is +0.00%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, VGLS is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check LABFF's competition here
VGLS vs SHJBF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, VGLS is priced at $0.13, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, VGLS's ROE is +0.00%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, VGLS is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SHJBF's competition here
VGLS vs ZLDPF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ZLDPF has a market cap of 3.6B. Regarding current trading prices, VGLS is priced at $0.13, while ZLDPF trades at $51.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is 3.64. In terms of profitability, VGLS's ROE is +0.00%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, VGLS is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ZLDPF's competition here
VGLS vs TLPPF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, TLPPF has a market cap of 3.6B. Regarding current trading prices, VGLS is priced at $0.13, while TLPPF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is -525.00. In terms of profitability, VGLS's ROE is +0.00%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, VGLS is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check TLPPF's competition here
VGLS vs CAMRF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, VGLS is priced at $0.13, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 41.04. In terms of profitability, VGLS's ROE is +0.00%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, VGLS is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CAMRF's competition here
VGLS vs ASPHF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, VGLS is priced at $0.13, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, VGLS's ROE is +0.00%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, VGLS is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ASPHF's competition here
VGLS vs GNNSF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, VGLS is priced at $0.13, while GNNSF trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, VGLS's ROE is +0.00%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, VGLS is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check GNNSF's competition here
VGLS vs BRCTF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, VGLS is priced at $0.13, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is 26.85. In terms of profitability, VGLS's ROE is +0.00%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, VGLS is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BRCTF's competition here
VGLS vs MPSYF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, VGLS is priced at $0.13, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, VGLS's ROE is +0.00%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, VGLS is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check MPSYF's competition here
VGLS vs BVNRY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BVNRY has a market cap of 2.5B. Regarding current trading prices, VGLS is priced at $0.13, while BVNRY trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 11.36. In terms of profitability, VGLS's ROE is +0.00%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, VGLS is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BVNRY's competition here
VGLS vs BVNKF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, VGLS is priced at $0.13, while BVNKF trades at $30.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 11.17. In terms of profitability, VGLS's ROE is +0.00%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, VGLS is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BVNKF's competition here
VGLS vs INCPF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, VGLS is priced at $0.13, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is 25.83. In terms of profitability, VGLS's ROE is +0.00%, compared to INCPF's ROE of +0.09%. Regarding short-term risk, VGLS is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check INCPF's competition here
VGLS vs ASCLF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ASCLF has a market cap of 2.2B. Regarding current trading prices, VGLS is priced at $0.13, while ASCLF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -42.00. In terms of profitability, VGLS's ROE is +0.00%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, VGLS is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ASCLF's competition here
VGLS vs GENSF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, VGLS is priced at $0.13, while GENSF trades at $33.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is 34.90. In terms of profitability, VGLS's ROE is +0.00%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, VGLS is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check GENSF's competition here
VGLS vs GLPGF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, VGLS is priced at $0.13, while GLPGF trades at $33.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, VGLS's ROE is +0.00%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, VGLS is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check GLPGF's competition here
VGLS vs MEOBF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, VGLS is priced at $0.13, while MEOBF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -22.86. In terms of profitability, VGLS's ROE is +0.00%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, VGLS is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check MEOBF's competition here
VGLS vs PHMMF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, VGLS is priced at $0.13, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, VGLS's ROE is +0.00%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, VGLS is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check PHMMF's competition here
VGLS vs ONTTF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, VGLS is priced at $0.13, while ONTTF trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -8.30. In terms of profitability, VGLS's ROE is +0.00%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, VGLS is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ONTTF's competition here
VGLS vs BIESF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, VGLS is priced at $0.13, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -44.44. In terms of profitability, VGLS's ROE is +0.00%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, VGLS is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BIESF's competition here
VGLS vs CSPHF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CSPHF has a market cap of 1.5B. Regarding current trading prices, VGLS is priced at $0.13, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, VGLS's ROE is +0.00%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, VGLS is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CSPHF's competition here
VGLS vs HBMHF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, VGLS is priced at $0.13, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, VGLS's ROE is +0.00%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, VGLS is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check HBMHF's competition here
VGLS vs SNBIF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, VGLS is priced at $0.13, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, VGLS's ROE is +0.00%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, VGLS is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SNBIF's competition here
VGLS vs PHGUF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, VGLS is priced at $0.13, while PHGUF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is -175.00. In terms of profitability, VGLS's ROE is +0.00%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, VGLS is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check PHGUF's competition here
VGLS vs MDCLF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, VGLS is priced at $0.13, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, VGLS's ROE is +0.00%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, VGLS is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check MDCLF's competition here
VGLS vs NURPF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, VGLS is priced at $0.13, while NURPF trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 55.16. In terms of profitability, VGLS's ROE is +0.00%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, VGLS is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check NURPF's competition here
VGLS vs CSBTF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, VGLS is priced at $0.13, while CSBTF trades at $27.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is 347.38. In terms of profitability, VGLS's ROE is +0.00%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, VGLS is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CSBTF's competition here
VGLS vs IDRSF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, VGLS is priced at $0.13, while IDRSF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -6.55. In terms of profitability, VGLS's ROE is +0.00%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, VGLS is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check IDRSF's competition here
VGLS vs PPTDF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, PPTDF has a market cap of 1B. Regarding current trading prices, VGLS is priced at $0.13, while PPTDF trades at $7.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is -44.39. In terms of profitability, VGLS's ROE is +0.00%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, VGLS is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check PPTDF's competition here
VGLS vs BTTAY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, VGLS is priced at $0.13, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, VGLS's ROE is +0.00%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, VGLS is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BTTAY's competition here
VGLS vs TKBIF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, VGLS is priced at $0.13, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, VGLS's ROE is +0.00%, compared to TKBIF's ROE of N/A. Regarding short-term risk, VGLS is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check TKBIF's competition here
VGLS vs BPMUF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BPMUF has a market cap of 853.7M. Regarding current trading prices, VGLS is priced at $0.13, while BPMUF trades at $69.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 9.77. In terms of profitability, VGLS's ROE is +0.00%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, VGLS is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BPMUF's competition here
VGLS vs IVEVF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, IVEVF has a market cap of 799.6M. Regarding current trading prices, VGLS is priced at $0.13, while IVEVF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -2.58. In terms of profitability, VGLS's ROE is +0.00%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, VGLS is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check IVEVF's competition here
VGLS vs VBIZF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, VGLS is priced at $0.13, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, VGLS's ROE is +0.00%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, VGLS is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check VBIZF's competition here
VGLS vs CKDXF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, VGLS is priced at $0.13, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, VGLS's ROE is +0.00%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, VGLS is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CKDXF's competition here
VGLS vs SOLTF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SOLTF has a market cap of 579.2M. Regarding current trading prices, VGLS is priced at $0.13, while SOLTF trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -7.36. In terms of profitability, VGLS's ROE is +0.00%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, VGLS is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SOLTF's competition here
VGLS vs GNFTF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, GNFTF has a market cap of 553.4M. Regarding current trading prices, VGLS is priced at $0.13, while GNFTF trades at $11.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is -5.47. In terms of profitability, VGLS's ROE is +0.00%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, VGLS is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check GNFTF's competition here
VGLS vs CYDY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CYDY has a market cap of 507.5M. Regarding current trading prices, VGLS is priced at $0.13, while CYDY trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -9.29. In terms of profitability, VGLS's ROE is +0.00%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, VGLS is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CYDY's competition here
VGLS vs INRLF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, INRLF has a market cap of 504.2M. Regarding current trading prices, VGLS is priced at $0.13, while INRLF trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -3.71. In terms of profitability, VGLS's ROE is +0.00%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, VGLS is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check INRLF's competition here
VGLS vs RAONF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, VGLS is priced at $0.13, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -43.33. In terms of profitability, VGLS's ROE is +0.00%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, VGLS is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check RAONF's competition here
VGLS vs GNFTY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, VGLS is priced at $0.13, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, VGLS's ROE is +0.00%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, VGLS is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check GNFTY's competition here
VGLS vs TBGNF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, VGLS is priced at $0.13, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, VGLS's ROE is +0.00%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, VGLS is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check TBGNF's competition here
VGLS vs PTCHF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, PTCHF has a market cap of 428.4M. Regarding current trading prices, VGLS is priced at $0.13, while PTCHF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is 10.35. In terms of profitability, VGLS's ROE is +0.00%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, VGLS is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check PTCHF's competition here
VGLS vs NWPHF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, VGLS is priced at $0.13, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is N/A. In terms of profitability, VGLS's ROE is +0.00%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, VGLS is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check NWPHF's competition here
VGLS vs AVCTF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, AVCTF has a market cap of 390.7M. Regarding current trading prices, VGLS is priced at $0.13, while AVCTF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -5.95. In terms of profitability, VGLS's ROE is +0.00%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, VGLS is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check AVCTF's competition here
VGLS vs CLVLY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CLVLY has a market cap of 351.4M. Regarding current trading prices, VGLS is priced at $0.13, while CLVLY trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 15.56. In terms of profitability, VGLS's ROE is +0.00%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, VGLS is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CLVLY's competition here
VGLS vs SLNCF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SLNCF has a market cap of 340.1M. Regarding current trading prices, VGLS is priced at $0.13, while SLNCF trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -3.81. In terms of profitability, VGLS's ROE is +0.00%, compared to SLNCF's ROE of -3.59%. Regarding short-term risk, VGLS is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SLNCF's competition here
VGLS vs CLVLF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CLVLF has a market cap of 315.2M. Regarding current trading prices, VGLS is priced at $0.13, while CLVLF trades at $6.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 12.56. In terms of profitability, VGLS's ROE is +0.00%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, VGLS is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CLVLF's competition here
VGLS vs NGENF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, VGLS is priced at $0.13, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -15.19. In terms of profitability, VGLS's ROE is +0.00%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, VGLS is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check NGENF's competition here
VGLS vs SPHDF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SPHDF has a market cap of 312.8M. Regarding current trading prices, VGLS is priced at $0.13, while SPHDF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -3.23. In terms of profitability, VGLS's ROE is +0.00%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, VGLS is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SPHDF's competition here
VGLS vs FGHQF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, VGLS is priced at $0.13, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, VGLS's ROE is +0.00%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, VGLS is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check FGHQF's competition here
VGLS vs NWBO Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, NWBO has a market cap of 302.4M. Regarding current trading prices, VGLS is priced at $0.13, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -3.27. In terms of profitability, VGLS's ROE is +0.00%, compared to NWBO's ROE of +0.72%. Regarding short-term risk, VGLS is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check NWBO's competition here
VGLS vs PBBIF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, VGLS is priced at $0.13, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, VGLS's ROE is +0.00%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, VGLS is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check PBBIF's competition here
VGLS vs ORPOF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, VGLS is priced at $0.13, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, VGLS's ROE is +0.00%, compared to ORPOF's ROE of N/A. Regarding short-term risk, VGLS is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ORPOF's competition here
VGLS vs ORYZF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, VGLS is priced at $0.13, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, VGLS's ROE is +0.00%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, VGLS is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ORYZF's competition here
VGLS vs HLOSF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, HLOSF has a market cap of 247.6M. Regarding current trading prices, VGLS is priced at $0.13, while HLOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -13.53. In terms of profitability, VGLS's ROE is +0.00%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, VGLS is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check HLOSF's competition here
VGLS vs HNSBF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, VGLS is priced at $0.13, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -4.08. In terms of profitability, VGLS's ROE is +0.00%, compared to HNSBF's ROE of +1.23%. Regarding short-term risk, VGLS is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check HNSBF's competition here
VGLS vs SPHRY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SPHRY has a market cap of 226.5M. Regarding current trading prices, VGLS is priced at $0.13, while SPHRY trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SPHRY's P/E ratio is -89.67. In terms of profitability, VGLS's ROE is +0.00%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, VGLS is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SPHRY's competition here
VGLS vs CMVLF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, VGLS is priced at $0.13, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, VGLS's ROE is +0.00%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, VGLS is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CMVLF's competition here
VGLS vs CAIHF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, VGLS is priced at $0.13, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, VGLS's ROE is +0.00%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, VGLS is more volatile compared to CAIHF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check CAIHF's competition here
VGLS vs BOVNF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, VGLS is priced at $0.13, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, VGLS's ROE is +0.00%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, VGLS is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BOVNF's competition here
VGLS vs FPHAF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, VGLS is priced at $0.13, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, VGLS's ROE is +0.00%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, VGLS is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check FPHAF's competition here
VGLS vs ADOCY Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, VGLS is priced at $0.13, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, VGLS's ROE is +0.00%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, VGLS is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ADOCY's competition here
VGLS vs SCNLF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SCNLF has a market cap of 147.4M. Regarding current trading prices, VGLS is priced at $0.13, while SCNLF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -14.20. In terms of profitability, VGLS's ROE is +0.00%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, VGLS is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SCNLF's competition here
VGLS vs SPHRF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, SPHRF has a market cap of 147.3M. Regarding current trading prices, VGLS is priced at $0.13, while SPHRF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas SPHRF's P/E ratio is -35.00. In terms of profitability, VGLS's ROE is +0.00%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, VGLS is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check SPHRF's competition here
VGLS vs TRGNF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, TRGNF has a market cap of 144.2M. Regarding current trading prices, VGLS is priced at $0.13, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, VGLS's ROE is +0.00%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, VGLS is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check TRGNF's competition here
VGLS vs AMGXF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, VGLS is priced at $0.13, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, VGLS's ROE is +0.00%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, VGLS is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check AMGXF's competition here
VGLS vs IPHYF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, IPHYF has a market cap of 140.7M. Regarding current trading prices, VGLS is priced at $0.13, while IPHYF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -2.31. In terms of profitability, VGLS's ROE is +0.00%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, VGLS is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check IPHYF's competition here
VGLS vs KNTPF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, KNTPF has a market cap of 140.7M. Regarding current trading prices, VGLS is priced at $0.13, while KNTPF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas KNTPF's P/E ratio is -5.00. In terms of profitability, VGLS's ROE is +0.00%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, VGLS is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check KNTPF's competition here
VGLS vs BRIBF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, VGLS is priced at $0.13, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, VGLS's ROE is +0.00%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, VGLS is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BRIBF's competition here
VGLS vs HBPCF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, VGLS is priced at $0.13, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, VGLS's ROE is +0.00%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, VGLS is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check HBPCF's competition here
VGLS vs AAPGV Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, VGLS is priced at $0.13, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, VGLS's ROE is +0.00%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, VGLS is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check AAPGV's competition here
VGLS vs BXPHF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, BXPHF has a market cap of 119.4M. Regarding current trading prices, VGLS is priced at $0.13, while BXPHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas BXPHF's P/E ratio is -2.00. In terms of profitability, VGLS's ROE is +0.00%, compared to BXPHF's ROE of -1.31%. Regarding short-term risk, VGLS is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check BXPHF's competition here
VGLS vs PSTTF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, VGLS is priced at $0.13, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, VGLS's ROE is +0.00%, compared to PSTTF's ROE of N/A. Regarding short-term risk, VGLS is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check PSTTF's competition here
VGLS vs JWCTF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, JWCTF has a market cap of 116.6M. Regarding current trading prices, VGLS is priced at $0.13, while JWCTF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, VGLS's ROE is +0.00%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, VGLS is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check JWCTF's competition here
VGLS vs ATGGF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ATGGF has a market cap of 113.5M. Regarding current trading prices, VGLS is priced at $0.13, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ATGGF's P/E ratio is N/A. In terms of profitability, VGLS's ROE is +0.00%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, VGLS is more volatile compared to ATGGF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ATGGF's competition here
VGLS vs NDTP Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, NDTP has a market cap of 112M. Regarding current trading prices, VGLS is priced at $0.13, while NDTP trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas NDTP's P/E ratio is -2.41. In terms of profitability, VGLS's ROE is +0.00%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, VGLS is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check NDTP's competition here
VGLS vs EPRXF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, VGLS is priced at $0.13, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, VGLS's ROE is +0.00%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, VGLS is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check EPRXF's competition here
VGLS vs ADOIF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, VGLS is priced at $0.13, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, VGLS's ROE is +0.00%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, VGLS is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check ADOIF's competition here
VGLS vs MSCLF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, VGLS is priced at $0.13, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, VGLS's ROE is +0.00%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, VGLS is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check MSCLF's competition here
VGLS vs PRRUF Comparison April 2026
VGLS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VGLS stands at 2.6B. In comparison, PRRUF has a market cap of 95.8M. Regarding current trading prices, VGLS is priced at $0.13, while PRRUF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VGLS currently has a P/E ratio of N/A, whereas PRRUF's P/E ratio is -0.93. In terms of profitability, VGLS's ROE is +0.00%, compared to PRRUF's ROE of -0.53%. Regarding short-term risk, VGLS is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for VGLS.Check PRRUF's competition here